News

Our latest press releases, media appearances and topical commentary.





News
17 March 2026
New Medicines Discovery Catapult and CPI project boosts UK capability in next-generation RNA medicines





Read more
News
13 March 2026
Medicines Discovery Catapult energises over 600 young ‘Medicine Makers’ for British Science Week 


Read more
News
23 February 2026
From models to medicines: ABPI and NC3Rs release landmark report


Read more
News
12 January 2026
Professor Chris Molloy, Chief Executive Officer of Medicines Discovery Catapult, steps down after ten years at the helm


Read more
News
18 November 2025
UK nuclear revolution powers next-generation precision cancer therapies 


Read more
News
11 November 2025
£15.9m Investment to Power Next-Generation Human Disease Modelling


Read more
News
07 October 2025
Medicines Discovery Catapult Announced as Newest Innovate UK Knowledge Base, Supporting Life Science Sector Growth   


Read more
News
01 October 2025
PACE Announces £6 Million Funding for Antibacterial Treatment Innovations to Fill Critical Gap in R&D Pipeline  


Read more
News
11 September 2025
Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation


Read more
News
04 September 2025
Breakthrough Glioblastoma Treatments Move Closer to Patients as Medicines Discovery Catapult and King’s College London Secure Brain Tumour Charity Funding


Read more





Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult